Levin, Yuval
January 2007
Human Life Review;Winter2007, Vol. 33 Issue 1, p103
The article presents views and insights concerning the embryonic-stem-cell-research in the U.S. The House of Representatives plans to take up once again a bill that would overturn President George Bush's stem-cell-research-funding policy, and have the government use taxpayer money to encourage the destruction of embryos for their cells. Information about the reaction of the public over the issue is also discussed.


Related Articles

  • Still strict on stem cells. Wadman, Meredith // Nature;4/23/2009, Vol. 458 Issue 7241, p950 

    The article discusses provisional rules for federally-funded stem-cell research issued by the U.S. National Institutes of Health (NIH). The reaction among researchers was mixed as critics believe they are too restrictive regarding use of embryos created for research using "in vitro"...

  • Senate to Hold Hearing on Funding for Stem Cells. Young, Donna // BioWorld Today;8/30/2010, Vol. 21 Issue 167, p1 

    The article discusses calls by Senator Tom Harkin for a hearing in September 2010 to discuss proposals to ensure federal funding for human embryonic stem cell (hESC) research. The U.S. Senate Appropriations Subcommittee on Labor, Health and Human services, Education and Related Agencies will...

  • A non-issue for years, vetoes now on congressional radar. Young, Jeffrey // Hill;6/28/2007, Vol. 14 Issue 79, p19 

    The article focuses on the vetoes made by U.S. President George W. Bush among proposed bills. Bush's first veto under his presidency is about a legislation that would expand federal funding for embryonic stem cell research. According to the author, Bush already has vetoed three bills and...

  • Will Stem Cell Policy Evolve? Heath, Erin // BioScience;Dec2005, Vol. 55 Issue 12, p1040 

    The article reflects on the possibility of embryonic stem cell research policy in the U.S. It is revealed that government restrictions on funding embryonic stem cell research continue to serve as problems to scientists. Opponents of embryonic stem cell research argue that it is unethical to...

  • Clinical Research: NIH Has Implemented Key Provisions of the Clinical Research Enhancement Act: GAO-02-965.  // GAO Reports;9/18/2002, p1 

    Clinical research is critical for the development of strategies for the prevention, diagnosis, prognosis, treatment, and cure of diseases. Clinical research has been defined as patient-oriented research, epidemiologic and behavioral studies, and outcomes research and health services research....

  • NIH Budget Battle Looms. Mitka, Mike // JAMA: Journal of the American Medical Association;11/10/2004, Vol. 292 Issue 18, p2205 

    Reports on medical news from Capitol Hill. Bills under consideration that would increase the budget for the National Institutes of Health; Differences between the House and Senate proposals under consideration; House bill which cuts funding to 2 grants awarded by the National Institute of Mental...

  • Frist backs stem cell legislation.  // Issues in Science & Technology;Fall2005, Vol. 22 Issue 1, p22 

    This article focuses on the move by U.S. Senate majority leader Bill Frist to support a legislation that would loosen President George W. Bush's restrictions on controversial embryonic stem cell research. Frist said that the limitations put in place in 2001 will slow the country's ability to...

  • Stem-cell law holds state back, MichBio panelists say. Dietderich, Andrew // Crain's Detroit Business;10/16/2006, Vol. 22 Issue 42, p29 

    The article reports on the responses of panelists at the second MichBio Expo regarding the laws of Michigan banning embryonic stem-cell research. The panelists believed that the laws need to be changed as the ban is leading to the loss of millions of dollars for the state. Sean Morrison,...

  • Additional £100m used to fund R&D into major diseases in the UK.  // PharmacoEconomics & Outcomes News;3/27/2004, Issue 449, p11 

    Reports on the additional £100 million budget which will be used to fund research and development into the treatment and cure of major disease in Great Britain including Alzheimer's disease. Use of the extra funding.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics